Refining the analysis for specific genes and cancer types revealed that two genes from the antigen presentation pathway (that is, B2M and CALR) displayed recurrent patterns of inactivating mutations and focal biallelic deletions across several tumor types, as well as in the pan-cancer cohorts (Fig. 6b–d). This evidence concerns the gene B2M and cancer.